Thermo Fisher Scientific (TMO) is a scientific instrument maker and a world leader in serving science. The company has three segments: Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics.Analysts have slashed their earnings expectations across the board, landing the stock into an unfavorable Zacks Rank #5 (Strong Sell).Image Source: Zacks Investment ResearchLet’s take a closer look at how the company currently stacks up. Thermo Fisher ScientificIt’s been a bumpy road for TMO shares year-to-date, down nearly 19% and unable to establish consistent strength. As we can see by the arrows circled below, shares have faced adverse recactions post-earnings in several instances throughout 2023. Image Source: Zacks Investment ResearchIn its latest release, the company beat the Zacks Consensus EPS Estimate by 2% and posted a fractional revenue surprise. Earnings saw growth of 12% year-over-year, whereas revenue declined by roughly 1% from the year-ago period. Image Source: Zacks Investment ResearchIn addition, Thermo Fisher lowered its FY23 guidance following the results, citing a challenging macroeconomic environment. The company now expects FY23 sales to be $42.7 billion and adjusted EPS of $21.50.It’s worth noting that Thermo Fisher had already lowered FY23 guidance back in July, further reflected by share performance over the last several months.The company has gone a long way in growing its dividend payout, carrying a sizable 16.5% five-year annualized dividend growth rate and reflecting its shareholder-friendly nature. TMO’s payout ratio sits at just 7% of its earnings. Image Source: Zacks Investment Research Bottom LineRecent guidance cuts due to a challenging macroeconomic environment paint a challenging picture for the company’s shares in the near term.Thermo Fisher Scientific is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company’s earnings outlook.For those seeking strong stocks, a great idea would be to focus on stocks carrying a Zacks Rank #1 (Strong Buy) or a Zacks Rank #2 (Buy) – these stocks sport a notably stronger earnings outlook paired with the potential to deliver explosive gains in the near term.More By This Author:Disney Q4 Preview: Can Shares Turnaround?Markets Up Big Again; Apple Beats Modestly3 Goldman Sachs Mutual Funds For Impressive Returns